• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于树突状细胞的癌症疫苗。

Dendritic Cell-Based Cancer Vaccines.

机构信息

UPMC Hillman Cancer Center, Pittsburgh, PA 15213.

UPMC Hillman Cancer Center, Pittsburgh, PA 15213;

出版信息

J Immunol. 2018 Jan 15;200(2):443-449. doi: 10.4049/jimmunol.1701024.

DOI:10.4049/jimmunol.1701024
PMID:29311386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5880540/
Abstract

Dendritic cells (DC) are specialized immune cells that play a critical role in promoting an immune response against Ags, which can include foreign pathogenic Ags and self-tumor Ags. DC are capable of boosting a memory T cell response but most importantly they are effective initiators of naive T cell responses. Many years of studies have focused on the use of DC vaccines against cancer to initiate and shape an antitumor-specific immune response and/or boost existing spontaneous antitumor T cell responses. In this study we give a brief overview of DC biology, function, and cellular subsets, and review the current status of the field of DC as cancer vaccines.

摘要

树突状细胞(DC)是一种专门的免疫细胞,在促进针对抗原的免疫反应中起着关键作用,这些抗原包括外来的病原性抗原和自身肿瘤抗原。DC 能够增强记忆 T 细胞反应,但最重要的是,它们是有效启动幼稚 T 细胞反应的细胞。多年的研究集中在使用 DC 疫苗来对抗癌症,以启动和塑造针对肿瘤的特异性免疫反应和/或增强现有的自发抗肿瘤 T 细胞反应。在本研究中,我们简要概述了 DC 的生物学、功能和细胞亚群,并回顾了 DC 作为癌症疫苗领域的现状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af3/5880540/da6690115802/nihms906791f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af3/5880540/c7e39ce87c48/nihms906791f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af3/5880540/da6690115802/nihms906791f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af3/5880540/c7e39ce87c48/nihms906791f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af3/5880540/da6690115802/nihms906791f2.jpg

相似文献

1
Dendritic Cell-Based Cancer Vaccines.基于树突状细胞的癌症疫苗。
J Immunol. 2018 Jan 15;200(2):443-449. doi: 10.4049/jimmunol.1701024.
2
Dendritic cells and cancer immunotherapy.树突状细胞与癌症免疫疗法。
Curr Opin Immunol. 2014 Apr;27:26-32. doi: 10.1016/j.coi.2014.01.005. Epub 2014 Feb 8.
3
Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.基于树突状细胞的免疫疗法:现状与展望。
Clin Cancer Res. 2016 Apr 15;22(8):1897-906. doi: 10.1158/1078-0432.CCR-15-1399.
4
Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.采用封闭式电穿孔系统对自体肿瘤裂解物负载树突状细胞疫苗进行免疫治疗实体瘤。
Anticancer Res. 2013 Jul;33(7):2971-6.
5
mRNA-based dendritic cell vaccines.基于信使核糖核酸的树突状细胞疫苗
Expert Rev Vaccines. 2015 Feb;14(2):161-76. doi: 10.1586/14760584.2014.957684. Epub 2014 Sep 8.
6
Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.树突状细胞工程在肿瘤免疫治疗中的应用:从生物学到临床转化。
Immunotherapy. 2012 Jul;4(7):703-18. doi: 10.2217/imt.12.40.
7
Dendritic cells as vectors for immunotherapy of cancer.树突状细胞作为癌症免疫治疗的载体。
Semin Cancer Biol. 2003 Dec;13(6):439-47. doi: 10.1016/j.semcancer.2003.09.008.
8
Cancer vaccines based on dendritic cells loaded with tumor-associated antigens.基于负载肿瘤相关抗原的树突状细胞的癌症疫苗。
Cell Biol Toxicol. 2001;17(2):67-75. doi: 10.1023/a:1010944003649.
9
Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.基于树突状细胞的疫苗:从小鼠模型到临床癌症免疫治疗
Crit Rev Oncog. 2000;11(1):1-17.
10
Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment.用于癌症治疗的树突状细胞疫苗再度兴起。
Trends Cancer. 2018 Feb;4(2):119-137. doi: 10.1016/j.trecan.2017.12.007.

引用本文的文献

1
Crosstalk between heterogeneous cancer-associated fibroblast subpopulations and the immune system in breast cancer: key players and promising therapeutic targets.乳腺癌中异质性癌症相关成纤维细胞亚群与免疫系统之间的串扰:关键参与者和有前景的治疗靶点
J Exp Clin Cancer Res. 2025 Sep 1;44(1):263. doi: 10.1186/s13046-025-03527-z.
2
Mechanical interactions impact the functions of immune cells and their application in immunoengineering.机械相互作用影响免疫细胞的功能及其在免疫工程中的应用。
Adv Ther (Weinh). 2025 Jun 25. doi: 10.1002/adtp.202500067.
3
The Evidence That Brain Cancers Could Be Effectively Treated with In-Home Radiofrequency Waves.脑癌可通过家用射频波有效治疗的证据。
Cancers (Basel). 2025 Aug 15;17(16):2665. doi: 10.3390/cancers17162665.
4
Constructing the cure: engineering the next wave of antibody and cellular immune therapies.构建治愈方法:打造下一代抗体和细胞免疫疗法。
J Immunother Cancer. 2025 Aug 25;13(8):e011761. doi: 10.1136/jitc-2025-011761.
5
Role of Immunotherapy in Ovarian Cancer: Advances, Challenges, and Future Perspectives.免疫疗法在卵巢癌中的作用:进展、挑战及未来展望
Cancer Treat Res. 2025;129:187-220. doi: 10.1007/978-3-031-97242-3_10.
6
-induced activation of B cells from mice, nonhuman primates, and humans produces large numbers of uniformly activated antigen presenting cells.诱导小鼠、非人灵长类动物和人类的B细胞活化可产生大量均匀活化的抗原呈递细胞。
bioRxiv. 2025 Jul 31:2025.07.25.666778. doi: 10.1101/2025.07.25.666778.
7
Natural carrier systems in cancer vaccines and immunotherapy.癌症疫苗和免疫疗法中的天然载体系统。
Hum Vaccin Immunother. 2025 Dec;21(1):2535787. doi: 10.1080/21645515.2025.2535787. Epub 2025 Jul 24.
8
Glioblastoma at the crossroads: current understanding and future therapeutic horizons.处于十字路口的胶质母细胞瘤:当前的认识与未来的治疗前景
Signal Transduct Target Ther. 2025 Jul 9;10(1):213. doi: 10.1038/s41392-025-02299-4.
9
Bibliometric analysis of immunotherapy in treatment of uveal melanoma.葡萄膜黑色素瘤免疫治疗的文献计量分析
Medicine (Baltimore). 2025 Jun 20;104(25):e42932. doi: 10.1097/MD.0000000000042932.
10
Efficacy of Using Dendritic Cells in the Treatment of Prostate Cancer: A Systematic Review.使用树突状细胞治疗前列腺癌的疗效:一项系统评价
Int J Mol Sci. 2025 May 21;26(10):4939. doi: 10.3390/ijms26104939.

本文引用的文献

1
Lineage specification of human dendritic cells is marked by IRF8 expression in hematopoietic stem cells and multipotent progenitors.人类树突状细胞的谱系特化以造血干细胞和多能祖细胞中IRF8的表达为标志。
Nat Immunol. 2017 Aug;18(8):877-888. doi: 10.1038/ni.3789. Epub 2017 Jun 26.
2
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.肿瘤驻留的Batf3树突状细胞是效应T细胞转运和过继性T细胞治疗所必需的。
Cancer Cell. 2017 May 8;31(5):711-723.e4. doi: 10.1016/j.ccell.2017.04.003.
3
Tumor Microenvironment: No Effector T Cells without Dendritic Cells.肿瘤微环境:没有树突状细胞就没有效应 T 细胞。
Cancer Cell. 2017 May 8;31(5):614-615. doi: 10.1016/j.ccell.2017.04.007.
4
Immunogenic cell death in cancer and infectious disease.肿瘤和传染病中的免疫原性细胞死亡
Nat Rev Immunol. 2017 Feb;17(2):97-111. doi: 10.1038/nri.2016.107. Epub 2016 Oct 17.
5
Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer.通过可植入式淋巴管端口向晚期癌症患者体内持续输注树突状细胞。
J Immunother Cancer. 2016 Apr 19;4:24. doi: 10.1186/s40425-016-0128-y. eCollection 2016.
6
Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.基于树突状细胞的免疫疗法:现状与展望。
Clin Cancer Res. 2016 Apr 15;22(8):1897-906. doi: 10.1158/1078-0432.CCR-15-1399.
7
Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells.树突状-肿瘤细胞杂交体比单纯的树突状细胞和肿瘤细胞混合物更有效地诱导肿瘤特异性免疫反应。
Cytotherapy. 2016 Apr;18(4):570-80. doi: 10.1016/j.jcyt.2016.01.005.
8
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma.自体单核细胞来源的 mRNA 电穿孔树突状细胞(TriMixDC-MEL)联合伊匹单抗治疗预处理晚期黑色素瘤患者的 II 期研究。
J Clin Oncol. 2016 Apr 20;34(12):1330-8. doi: 10.1200/JCO.2015.63.4121. Epub 2016 Feb 29.
9
Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation.调节性树突状细胞在器官移植中的前瞻性临床试验
Front Immunol. 2016 Jan 28;7:15. doi: 10.3389/fimmu.2016.00015. eCollection 2016.
10
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells.原发性髓系树突状细胞疫苗接种转移性黑色素瘤患者的有效临床应答。
Clin Cancer Res. 2016 May 1;22(9):2155-66. doi: 10.1158/1078-0432.CCR-15-2205. Epub 2015 Dec 28.